Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder

Journal of Affective Disorders

Volumn 107, Issue 1-3, 2008, Pages 127-133

  McElroy, Susan L ^a   Bowden, Charles L ^b   Collins, Michelle A ^c   Wozniak, Patricia J ^c   Keck Jr , Paul E ^a,d   Calabrese, Joseph R ^e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c ABBOTT LABORATORIES   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Bipolar; Divalproex; Lithium; Maintenance; Valproate

Indexed keywords

HALOPERIDOL; LITHIUM; LORAZEPAM; PAROXETINE; PLACEBO; SERTRALINE; VALPROATE SEMISODIUM;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME; VALPROIC ACID;

EID: 39649111102     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.08.014     Document Type: Article

References (16)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (Revision). Am. J. Psychiatry 159 4 Suppl 1 (2002) 1-50
2. Bowden C.L. Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. J. Clin. Psychiatry 59 Suppl 6 (1998) 13-19
3. Bowden C.L., Swann A.C., Calabrese J.R., McElroy S.L., Morris D., Petty F., Hirschfeld R.M.A., and Gyulai L. Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. Psychopharmacol. Bull. 33 4 (1997) 693-698
4. Bowden C.L., Calabrese J.R., McElroy S.L., Gyulai L., Wassef A., Petty F., Pope Jr. H.G., Chou J.C., Keck Jr. P.E., Rhodes L.J., Swann A.C., Hirschfeld R.M., and Wozniak P.J. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch. Gen. Psychiatry 57 (2000) 481-489
5. Bowden C.L., Calabrese J.R., Sachs G., Yatham L.N., Asghar S.A., Hompland M., Montgomery P., Earl N., Smoot T.M., and DeVeaugh-Geiss J. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 60 (2003) 392-400
6. Calabrese J.R., and Rapport D.J. Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder. J. Clin. Psychiatry 60 Suppl 5 (1999) 5-13
7. Calabrese J.R., Suppes T., Bowden C.L., Sachs G.S., Swann A.C., McElroy S.L., Kusumaker V., Ascher J.A., Earl N.L., Greene P.L., and Monaghan E.T. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J. Clin. Psychiatry 61 (2000) 841-850
8. Calabrese J.R., Bowden C.L., Sachs G., Yatham L.N., Behnke K., Mehtonen O.P., Montgomery P., Ascher J., Paska W., Earl N., and DeVeaugh-Geiss J. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64 (2003) 1013-1024
9. Endicott J., and Spitzer R.L. A diagnostic interview: the schedule of affective disorders and schizophrenia. Arch. Gen. Psychiatry 35 (1978) 837-844
10. Fountoulakis K.N., Vieta E., Sanches-Moreno J., Kaprinis S.G., Goikolea J.M., and Kaprinis G.S. Treatment guidelines for bipolar disorder: a critical review. J. Affect. Disord. 86 (2005) 1-10
11. Keck Jr. P.E., Perlis R.H., Otto M.W., Carpenter D., Ross R., and Docherty J.P. Treatment of bipolar disorder. The expert consensus guidelines series (2004), Postgraduate Medicine
12. SAS/STAT User's Guide,Version 6. 4th ed. Cary, NC: SAS Institute Inc;1989.
13. Smith L.A., Cornelius V., Warnock A., Bell A., and Young A.H. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord. 9 (2007) 394-412
14. Spitzer R.L., Williams J.B.W., and Gibbons M. Structured Clinical Interview for the DSM-III-R (1990), American Psychiatric Press Inc., Washington, DC
15. Tohen M., Calabrese J.R., Sachs G.S., Banov M.D., Detke H.C., Risser R., Baker R.W., Chou J.C., and Bowden C.L. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am. J. Psychiatry 163 (2006) 247-256
16. Tohen M., Greil W., Calabrese J.R., Sachs G.S., Yatham L.N., Oerlinghausen B.M., Koukopoulos A., Cassano G.B., Grunze H., Licht R.W., Dell'Osso L., Evans A.R., Risser R., Baker R.W., Crane H., Dosser M.R., and Bowden C.L. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am. J. Psychiatry 162 (2005) 1281-1290